Regency Centers (REG)

NASDAQReal EstateReit - RetailSnapshot 2026-10-15

$73.24+0.27%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Regency Centers’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.7%

+10% or more+5%0%−5%−10% or less

2.55 → 2.53 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

4 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Maintain strong cash from operations near recent levels	A supporting condition in Regency Centers's published investment case. The stated target is >=150 million USD per quarter.	Intact	Cash from operations falls below $150 million per quarter	Cash from operations: $281.301M FY2026-Q2; GAAP. Published target: >=150 million USD per quarter. Target period is not explicitly aligned with this observation. Source published Aug 3, 2026281,301,000 USD · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Quarterly dividend at least $0.755 per share	It raised its dividend to $0.755 per share.	Intact	Dividend per share falls below $0.755 quarterly	Dividend per share: $0.76 per share FY2026-Q2; GAAP. Published target: >=0.755 USD per share quarterly. Target period is not explicitly aligned with this observation. Source published Aug 3, 20260.755 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: e866e505-5356-4a1f-b804-f0985032a99b. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Reaffirm 2026 earnings guidance at $4.83-$4.87 per share	Management reaffirmed 2026 earnings guidance near $4.87 per share.	Broken	EPS guidance falls below $4.83 per share for FY26	Diluted EPS: $0.61 per share FY2026-Q2; GAAP. Published target: >=4.83 USD per share. Target period is not explicitly aligned with this observation. Source published Aug 3, 20260.61 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Same property NOI growth between 3.25% and 3.75%	Same property NOI growth is expected between 3.25% and 3.75%.	Intact	Same Property NOI growth falls below 3.25% YoY in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$2.53

$2.55 → $2.53 · observed estimates

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$2.55	Unavailable	8 / 4
2026-07-25	$2.52	Unavailable	7 / 4
2026-07-26	$2.55	Unavailable	8 / 4
2026-07-27	$2.52	Unavailable	7 / 4
2026-07-28	$2.52	Unavailable	7 / 4
2026-07-29	$2.52	Unavailable	7 / 4
2026-07-30	$2.55	Unavailable	8 / 4
2026-07-31	$2.52	Unavailable	7 / 4
2026-08-01	$2.55	Unavailable	8 / 4
2026-08-02	$2.52	Unavailable	7 / 4
2026-08-03	$2.55	Unavailable	8 / 4
2026-08-04	$2.55	Unavailable	8 / 4
2026-08-05	$2.55	Unavailable	8 / 4
2026-08-06	$2.55	Unavailable	8 / 4
2026-08-08	$2.52	Unavailable	7 / 4
2026-08-09	$2.55	Unavailable	8 / 4
2026-08-10	$2.55	Unavailable	8 / 4
2026-08-12	$2.52	Unavailable	7 / 4
2026-08-13	$2.55	Unavailable	8 / 4
2026-08-14	$2.55	Unavailable	8 / 4
2026-08-15	$2.55	Unavailable	8 / 4
2026-08-16	$2.55	Unavailable	8 / 4
2026-08-17	$2.55	Unavailable	8 / 4
2026-08-18	$2.55	Unavailable	8 / 4
2026-08-19	$2.55	Unavailable	8 / 4
2026-08-20	$2.61	Unavailable	8 / 4
2026-08-21	$2.61	Unavailable	8 / 4
2026-08-22	$2.61	Unavailable	8 / 4
2026-08-23	$2.61	Unavailable	8 / 4
2026-08-24	$2.61	Unavailable	8 / 4
2026-08-25	$2.61	Unavailable	8 / 4
2026-08-26	$2.61	Unavailable	8 / 4
2026-08-27	$2.61	Unavailable	8 / 4
2026-08-28	$2.61	Unavailable	8 / 4
2026-08-29	$2.61	Unavailable	8 / 4
2026-08-30	$2.61	Unavailable	8 / 4
2026-08-31	$2.61	Unavailable	7 / 4
2026-09-01	$2.55	Unavailable	7 / 4
2026-09-02	$2.55	Unavailable	8 / 4
2026-09-03	$2.55	Unavailable	8 / 4
2026-09-04	$2.55	Unavailable	8 / 4
2026-09-05	$2.55	Unavailable	8 / 4
2026-09-06	$2.55	Unavailable	8 / 4
2026-09-07	$2.55	Unavailable	8 / 4
2026-09-08	$2.55	Unavailable	8 / 4
2026-09-09	$2.55	Unavailable	8 / 4
2026-09-10	$2.55	Unavailable	8 / 4
2026-09-11	$2.55	Unavailable	8 / 4
2026-09-12	$2.55	Unavailable	8 / 4
2026-09-13	$2.55	Unavailable	8 / 4
2026-09-14	$2.55	Unavailable	8 / 4
2026-09-15	$2.55	Unavailable	8 / 4
2026-09-16	$2.55	Unavailable	8 / 4
2026-09-17	$2.55	Unavailable	8 / 4
2026-09-18	$2.55	Unavailable	8 / 4
2026-09-19	$2.55	Unavailable	8 / 4
2026-09-20	$2.55	Unavailable	8 / 4
2026-09-21	$2.55	Unavailable	8 / 4
2026-09-22	$2.55	Unavailable	8 / 4
2026-09-23	$2.55	Unavailable	8 / 4
2026-09-24	$2.55	Unavailable	8 / 4
2026-09-25	$2.50	Unavailable	8 / 4
2026-09-26	$2.50	Unavailable	8 / 4
2026-09-27	$2.50	Unavailable	8 / 4
2026-09-28	$2.50	Unavailable	8 / 4
2026-09-29	$2.50	Unavailable	8 / 4
2026-09-30	$2.50	Unavailable	8 / 4
2026-10-01	$2.50	Unavailable	8 / 4
2026-10-02	$2.50	Unavailable	8 / 4
2026-10-03	$2.53	Unavailable	8 / 4
2026-10-04	$2.53	Unavailable	8 / 4
2026-10-05	$2.53	Unavailable	8 / 4
2026-10-06	$2.53	Unavailable	8 / 4
2026-10-07	$2.53	Unavailable	8 / 4
2026-10-08	$2.53	Unavailable	8 / 4
2026-10-09	$2.53	Unavailable	8 / 4
2026-10-10	$2.53	Unavailable	8 / 4
2026-10-11	$2.53	Unavailable	8 / 4
2026-10-12	$2.53	Unavailable	8 / 4
2026-10-13	$2.53	Unavailable	7 / 3
2026-10-14	$2.53	Unavailable	7 / 3
2026-10-15	$2.53	Unavailable	7 / 3

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	12	10
2026-06-01	11	10
2026-07-01	11	10
2026-08-01	11	10
2026-09-01	12	9
2026-10-01	12	8

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 12 Buy / Strong Buy · 8 Hold · 0 Sell / Strong Sell

1 upgrades0 downgrades6 maintains

Recent actions · Sep 16–Oct 15 · 7 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

UBSOct 9 · prior Jul 9

$85.00 → $77.00-9.4%

Morgan StanleyOct 5

$87.00New observation · no comparable prior

Truist FinancialOct 1

$84.00New observation · no comparable prior

BarclaysSep 28 · prior Aug 17

$92.00 → $85.00-7.6%

Goldman SachsSep 24

$83.00New observation · no comparable prior

GriffinSep 21

$81.00New observation · no comparable prior

ScotiabankSep 17

$81.00New observation · no comparable prior

$0$50.60$101.20

0 raises · 2 cuts · 0 unchanged · 5 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Maintain strong cash from operations near recent levelsCash from operations: $281.301M
Quarterly dividend at least $0.755 per shareDividend per share: $0.76 per share
Reaffirm 2026 earnings guidance at $4.83-$4.87 per sharePublished status: Broken
Same property NOI growth between 3.25% and 3.75%Direct metric needs a verified mapping

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.5%Typical daily move · historical

Downside history

-14.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Regency Centers outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a stable real estate play with a focus on consistent income through dividends and property performance. The current thesis state is mixed, with management showing commitment to growth and shareholder returns, but facing sector headwinds.

What's priced into Regency Centers

The market currently prices REG with a low fragility tier, indicating that while execution quality is weak, it is not overly expensive relative to peers. There is a small expectations gap, suggesting that the market anticipates modest performance moving forward.

What the fundamentals likely do

Management is focused on driving same property net operating income (NOI) growth and maintaining dividend payouts. Recent results show stable leasing activity and a commitment to development projects, though performance has been mixed.

What Regency Centers hinges on

The thesis hinges on several factors, including the potential for the Federal Reserve to cut interest rates, which could benefit real estate stocks. Additionally, performance from sector leaders like SPG, O, and KIM will be crucial for REG's momentum.